Hemoglobin therapy in hemodialysis
Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BLUE JOHN STERN KATHLEEN N MARCHAND GARY R PRZYBELSKI ROBERT J GARBER JAN W GONDER JANET C |
| description | Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5906974A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5906974A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5906974A3</originalsourceid><addsrcrecordid>eNrjZFDySM3NT8_JT8rMUyjJSC1KLKhUADIzgKIpmYk5lcWZxTwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JD402NTSwMzS3MTRmLAKAEGUJcY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Hemoglobin therapy in hemodialysis</title><source>esp@cenet</source><creator>BLUE; JOHN ; STERN; KATHLEEN N ; MARCHAND; GARY R ; PRZYBELSKI; ROBERT J ; GARBER; JAN W ; GONDER; JANET C</creator><creatorcontrib>BLUE; JOHN ; STERN; KATHLEEN N ; MARCHAND; GARY R ; PRZYBELSKI; ROBERT J ; GARBER; JAN W ; GONDER; JANET C</creatorcontrib><description>Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.</description><edition>6</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990525&DB=EPODOC&CC=US&NR=5906974A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990525&DB=EPODOC&CC=US&NR=5906974A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BLUE; JOHN</creatorcontrib><creatorcontrib>STERN; KATHLEEN N</creatorcontrib><creatorcontrib>MARCHAND; GARY R</creatorcontrib><creatorcontrib>PRZYBELSKI; ROBERT J</creatorcontrib><creatorcontrib>GARBER; JAN W</creatorcontrib><creatorcontrib>GONDER; JANET C</creatorcontrib><title>Hemoglobin therapy in hemodialysis</title><description>Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDySM3NT8_JT8rMUyjJSC1KLKhUADIzgKIpmYk5lcWZxTwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JD402NTSwMzS3MTRmLAKAEGUJcY</recordid><startdate>19990525</startdate><enddate>19990525</enddate><creator>BLUE; JOHN</creator><creator>STERN; KATHLEEN N</creator><creator>MARCHAND; GARY R</creator><creator>PRZYBELSKI; ROBERT J</creator><creator>GARBER; JAN W</creator><creator>GONDER; JANET C</creator><scope>EVB</scope></search><sort><creationdate>19990525</creationdate><title>Hemoglobin therapy in hemodialysis</title><author>BLUE; JOHN ; STERN; KATHLEEN N ; MARCHAND; GARY R ; PRZYBELSKI; ROBERT J ; GARBER; JAN W ; GONDER; JANET C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5906974A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BLUE; JOHN</creatorcontrib><creatorcontrib>STERN; KATHLEEN N</creatorcontrib><creatorcontrib>MARCHAND; GARY R</creatorcontrib><creatorcontrib>PRZYBELSKI; ROBERT J</creatorcontrib><creatorcontrib>GARBER; JAN W</creatorcontrib><creatorcontrib>GONDER; JANET C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BLUE; JOHN</au><au>STERN; KATHLEEN N</au><au>MARCHAND; GARY R</au><au>PRZYBELSKI; ROBERT J</au><au>GARBER; JAN W</au><au>GONDER; JANET C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Hemoglobin therapy in hemodialysis</title><date>1999-05-25</date><risdate>1999</risdate><abstract>Low doses of stroma-free diaspirin cross-linked hemoglobin are administered to patients undergoing hemodialysis, to achieve hemostabilization and avoid hypotensive episodes in susceptible patients. Hemoglobin therapy when implemented prophylactically in hemodialysis also partially obviates the need for further interventions to control circulatory system instability.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US5906974A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Hemoglobin therapy in hemodialysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A34%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BLUE;%20JOHN&rft.date=1999-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5906974A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |